Head & Neck Cancer, 23-24 September 2022, Singapore
Online application is open until 3 July 2022
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The leading professional organisation for medical oncology
ESMO Members are invited to cast their vote for the ESMO President 2025-2026 and the three Director 2023-2024 positions.
2-4 December: the leading oncology congress in Asia – Pacific is back in Singapore! Listen to Asian and international KOLs presenting their latest findings
Join the experts developing and implementing the ESMO Guidelines
Online application is open until 3 July 2022
Meet us in Amsterdam in October to network and debate on future challenges in the field of precision oncology with international researchers in the field.
Now available on-demand. Take the CME test and advance your knowledge in upper digestive cancers
A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
23-24 September 2022, Lisbon, Portugal
From ASCO 2022 Annual Meeting:
Preliminary findings indicate that patients with tumours harbouring NRG1 fusions may benefit from treatment with zenocutuzumab or seribantumab
Read more about how the global oncology community is responding to the humanitarian crisis
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.